Current global and Korean issues in radiation safety of nuclear medicine procedures. (June 2016)

• Record Type: Journal Article
• Authors: Song, H.C.
• Is Part Of: Annals of the ICRP. Volume 45:(2016)Supplement 1
• Page Start: 122
• Page End: 137
• Publication Date: 2016-06
• Subjects: Medical radiation -- Radiation safety -- Nuclear medicine procedures -- Justification -- Optimisation; Radiation -- Safety measures -- Periodicals; Radiation -- Physiological effect -- Periodicals; Radiation -- Toxicology -- Periodicals; Periodicals; 612.01448
• DOI: 10.1177/0146645315624048
• Languages: English
• ISSNs: 0146-6453

Abstract

In recent years, the management of patient doses in medical imaging has evolved as concern about radiation exposure has increased. Efforts and techniques to reduce radiation doses are focussed not only on the basis of patient safety, but also on the fundamentals of justification and optimisation in cooperation with international organisations such as the International Commission on Radiological Protection, the International Atomic Energy Agency, and the World Health Organization. The Image Gently campaign in children and Image Wisely campaign in adults to lower radiation doses have been initiated in the USA. The European Association of Nuclear Medicine paediatric dosage card, North American consensus guidelines, and Nuclear Medicine Global Initiative have recommended the activities of radiopharmaceuticals that should be administered in children. Diagnostic reference levels (DRLs), developed predominantly in Europe, may be an important tool to manage patient doses. In Korea, overexposure to radiation, even from the use of medical imaging, has become a public issue, particularly since the accident at the Fukushima nuclear power plant. As a result, the Korean Nuclear Safety and Security Commission revised the technical standards for radiation safety management in medical fields. In parallel, DRLs for nuclear medicine procedures have been collected on a nationwide scale. Notice of total effective dose from positron emission tomography-computed tomography for cancer screening has been mandatory since mid-November 2014.